[go: up one dir, main page]

ES2188928T3 - Pastilla de liberador-rapido s1452. - Google Patents

Pastilla de liberador-rapido s1452.

Info

Publication number
ES2188928T3
ES2188928T3 ES97915710T ES97915710T ES2188928T3 ES 2188928 T3 ES2188928 T3 ES 2188928T3 ES 97915710 T ES97915710 T ES 97915710T ES 97915710 T ES97915710 T ES 97915710T ES 2188928 T3 ES2188928 T3 ES 2188928T3
Authority
ES
Spain
Prior art keywords
release
pad
fast pad
main agent
fast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97915710T
Other languages
English (en)
Inventor
Eizou Wakamiya
Yoshikazu Suzuki
Hitoshi Kadota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2188928T3 publication Critical patent/ES2188928T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTA UNA PASTILLA DE S1452 DE LIBERACION RAPIDA QUE CONTIENE AL MENOS LOS SIGUIENTES COMPONENTES: A. UN AGENTE PRINCIPAL QUE CONTIENE EL DIHIDRATO DEL 7 [(1R,2S,3S,4S) - 3 - BENCENOSULFONAIDOCICLO[2.2.1]HEPT - 2 IL] - 5 - HEPTANOATO (+) - (Z) - CALCICO (S1452) Y B. UN DISPERSANTE EN UNA CANTIDAD SUFICIENTE PARA DISPERSAR EL AGENTE PRINCIPAL TRAS LA DESINTEGRACION DE LA PASTILLA.
ES97915710T 1996-04-26 1997-04-11 Pastilla de liberador-rapido s1452. Expired - Lifetime ES2188928T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10653396 1996-04-26

Publications (1)

Publication Number Publication Date
ES2188928T3 true ES2188928T3 (es) 2003-07-01

Family

ID=14436039

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97915710T Expired - Lifetime ES2188928T3 (es) 1996-04-26 1997-04-11 Pastilla de liberador-rapido s1452.

Country Status (7)

Country Link
US (1) US6056974A (es)
EP (1) EP0906754B1 (es)
AU (1) AU2308097A (es)
DE (1) DE69717810T2 (es)
ES (1) ES2188928T3 (es)
TW (1) TW464512B (es)
WO (1) WO1997040828A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69717810T2 (de) * 1996-04-26 2003-09-18 Shionogi & Co., Ltd. S1452-tabletten mit schneller freisetzung
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
DK1555898T3 (en) * 2002-10-31 2016-05-09 Philip Morris Products Sa Electrically heated cigarette including controlled release of flavor.
KR100691608B1 (ko) * 2005-02-21 2007-03-12 (주)나노하이브리드 염기성 고분자가 첨가된 유리 염기형 약물과 층상형 규산염의 하이브리드 및 그의 제조방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56152416A (en) * 1980-04-25 1981-11-26 Tsumura Juntendo Inc Preparation of chinese herbal remedy tablet
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS59500735A (ja) * 1983-04-18 1984-04-26 エス・ア−ル・アイ・インタ−ナシヨナル 人間の癌診断のための方法および試験キツト
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
CA1278577C (en) * 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
JPS63115815A (ja) * 1986-10-31 1988-05-20 Mitsubishi Kasei Corp 肝疾患治療薬組成物
JPS63119426A (ja) * 1986-11-06 1988-05-24 Mitsubishi Kasei Corp 肝疾患治療薬組成物
JP2565746B2 (ja) * 1987-10-23 1996-12-18 小野薬品工業株式会社 新規な炭素環系スルホンアミド誘導体
EP0312906A3 (en) * 1987-10-23 1990-09-05 Ono Pharmaceutical Co., Ltd. Novel sulfonamide derivatives
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
JPH0218086A (ja) * 1988-07-06 1990-01-22 Matsushita Electric Ind Co Ltd 光記録媒体および光記録再生方法
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
JPH0714910B2 (ja) * 1988-12-13 1995-02-22 塩野義製薬株式会社 安定な結晶性の塩およびそれを含有するトロンボキサン受容体拮抗剤
JP2676113B2 (ja) * 1989-06-13 1997-11-12 塩野義製薬株式会社 安定な結晶性の塩およびそれを含有するトロンボキサン受容体拮抗剤
DE69717810T2 (de) * 1996-04-26 2003-09-18 Shionogi & Co., Ltd. S1452-tabletten mit schneller freisetzung

Also Published As

Publication number Publication date
DE69717810D1 (de) 2003-01-23
WO1997040828A1 (fr) 1997-11-06
EP0906754A4 (en) 2000-01-12
AU2308097A (en) 1997-11-19
TW464512B (en) 2001-11-21
US6056974A (en) 2000-05-02
EP0906754A1 (en) 1999-04-07
EP0906754B1 (en) 2002-12-11
DE69717810T2 (de) 2003-09-18

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
SE9803680L (sv) Strålningshärdbara, cyanoakrylatinnehållande ko mpositioner
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
ES2166403T3 (es) Prenda de retencion de desperdicios, de un solo uso.
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
KR870005637A (ko) 약물 데포
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2161775T3 (es) Procedimiento para teñir fibras que contienen queratina.
AR023299A1 (es) UNA FORMULACION DE LIBERACION PROLONGADA DE UN COMPUESTO MACRoLIDO
AR003908A1 (es) Tableta de liberacion controlada
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
BR9502224A (pt) Composição de uso tópico e utilização de uma associação de um agente antioxidante e de ao menos um extrato de bactérias filamentosas não fotossintéticas e não frutificantes
AR020999A1 (es) Composiciones y proceso para la elaboracion de isotretinoina
ES2068202T3 (es) Composicion liquida suavizante para prendas de ropa.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
ES2184326T3 (es) Nuevos compuestos derivados del mentol y su utilizacion como agente refrescante.
MX9300550A (es) Estructura de fibra absorbente.
ES2070358T3 (es) Dispositivo para enclavar un espadin de aguja de ferrocarril.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
ES2161412T3 (es) Paquete de vacuna que comprende un recipiente con compuestos vacunales liofilizados.
CO5190673A1 (es) Nueva composicion y uso liberacion modificada
GB9725750D0 (en) Compound
ES2188928T3 (es) Pastilla de liberador-rapido s1452.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.